Updated on 2024/12/22

写真a

 
MIYAZAWA Haruna
 
Organization
University Medical and Dental Hospital Clinical and Translational Research Center Specially Appointed Lecturer
Title
Specially Appointed Lecturer
External link

Degree

  • 博士(歯学) ( 2013.3   新潟大学 )

Research Areas

  • Life Science / Medical management and medical sociology  / レギュラトリーサイエンス

  • Informatics / Life, health and medical informatics

  • Life Science / Conservative dentistry  / 歯周病学

Research History (researchmap)

  • Niigata University   Medical and Dental Hospital Clinical and Translational Research Center

    2024.1

      More details

  • Niigata University

    2022.7 - 2023.12

      More details

  • Niigata University

    2021.4 - 2022.6

      More details

  • Japan Agency for Medical Research and Development

    2020.4 - 2021.3

      More details

  • Japan Agency for Medical Research and Development

    2019.4 - 2020.3

      More details

  • Niigata University   Specially Appointed Assistant Professor

    2018.11 - 2019.3

      More details

  • 新潟大学医歯学総合病院   歯周病科   医員

    2014.12 - 2018.10

      More details

  • 新潟大学医歯学総合研究科   歯周診断・再建学分野   研究員

    2014.4 - 2014.11

      More details

▶ display all

Research History

  • Niigata University   Clinical and Translational Research Center, University Medical and Dental Hospital   Specially Appointed Lecturer

    2024.1

  • Niigata University   University Medical and Dental Hospital Clinical and Translational Research Center   Specially Appointed Assistant Professor

    2018.12 - 2023.12

Education

  • Niigata University   医歯学総合研究科   歯周診断・再建学分野

    2010.4 - 2014.3

      More details

  • Niigata University   Faculty of Dentistry   School of Dentistry

    2003.4 - 2009.3

      More details

Professional Memberships

Committee Memberships

  • 日本医療情報学会 栄養・運動・口腔保健・休養の自己管理のための保健医療情報研究会   幹事  

    2021.4   

      More details

  • 経済産業省事業 保健医療福祉リアルワールドデータ活用 促進のための国際標準化   「ヘルス&ケアデータプロセスモデル」国際規格開発委員会 委員  

    2021 - 2024.3   

      More details

Qualification acquired

  • Dentist

 

Papers

  • Concordance Between Pharmaceuticals and Medical Devices Agency Review and Ministry of Health, Labour and Welfare Decision Among New Drug Applications in Japan

    Makoto Miyazawa, Mototsugu Tanaka, Yusuke Tanaka, Ryohei Terashima, Mio Ezura, Haruna Miyazawa, Mutsuhiro Ikuma, Yoshihiko Tomita

    Clinical Pharmacology & Therapeutics   2024.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    New drug applications (NDAs) in Japan are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA). Those that pass the review are subsequently subject to deliberation by the Ministry of Health, Labour and Welfare Pharmaceutical Affairs and Food Sanitation Councils (MHLW‐PAFSC), and the MHLW legislatively grants approval based on its positive opinions. However, little is known regarding the relationship between the PMDA review and the MHLW decision. We retrospectively assessed the MHLW decision of NDAs that passed the PMDA review at the initial MHLW‐PAFSC deliberation from 2002 to 2022. The reasoning behind a non‐supportive opinion from the MHLW‐PAFSC and the sponsor's actions to overcome unresolved issues were also documented. A total of 2,117 of 2,153 (98.3%) NDAs that passed the PMDA review were approved at the initial MHLW‐PAFSC deliberation with a positive opinion. The remaining 36 applications were not approved at the initial deliberation and subjected to continued deliberation because of a non‐supportive opinion from the councils, although 29 were finally approved through revision of the application document (24 applications), re‐analysis of the data (1 application), or additional clinical trials (4 applications). Seven applications have not been approved, of which one was refused, four were withdrawn, and two were unknown. The MHLW approves NDAs that passed the PMDA review at the initial deliberation at a high rate, suggesting that NDAs only suitable for approval passed the review and reached the MHLW‐PAFSC deliberation. Only a few NDAs were not approved at the initial deliberation; however, most of them were finally approved.

    DOI: 10.1002/cpt.3485

    researchmap

  • Bioinformatic evaluation of the potential oral-gut translocation of periodontal pathogens in patients with colorectal polyps

    Naoki Takahashi, Marin Yamaguchi, Keisuke Sato, Takahiro Tsuzuno, Shuhei Mineo, Nao Nakajima, Kazuya Takahashi, Hiroki Sato, Haruna Miyazawa, Yukari Aoki-Nonaka, Yutaro Ito, Koji Taniguchi, Shuji Terai, Kohei Ito, Koichi Tabeta

    2024.5

     More details

    Publisher:Cold Spring Harbor Laboratory  

    Objective: This study aimed to characterize the profiles of the oral and gut microbiota of patients with colorectal polyps using 16S rRNA gene sequencing and bioinformatic approaches. Background: Previous studies have shown microbial translocation from the oral cavity to the gut, implying pathogenic impacts on gastroesophageal disease, including colorectal cancer (CRC). However, its details remain unclear. Methods: Twenty patients scheduled for endoscopic colorectal polypectomy were enrolled in this study. Oral samples (saliva and subgingival dental plaque) and intestinal samples (feces and swab of intestinal mucosa) were collected during preoperative and 6–month–postoperative reassessment periods. After sequencing the V3–V4 region of the bacterial 16S rRNA gene, several bioinformatic analyses (bacterial composition, diversity, core microbiome, and shared ASV) were performed on pre– and postoperative samples for each subject. Results: The bacterial composition was dominated by Bacteroides, Streptococcus, Fusobacterium, Veillonella, and Prevotella_7 in all four samples. Beta diversity analysis using weighted UniFrac distance distinctly segregated the samples between oral and intestinal environments in the principal coordinate analysis plot. Core microbiome analysis revealed that Streptococcus and Porphyromonas were dominantly shared in intra–oral environments. Additionally, alongside Streptococcus, periodontitis–related bacteria, such as Veillonella, Fusobacterium, Porphyromonas, Prevotella_7, Haemophilus, and Prevotella, were identified as shared genera between oral and intestinal environments. Finally, shared ASV analysis demonstrated that Streptococcus was shared in the oral and intestinal environments of most patients, while periodontal pathogens were shared in some patients. Conclusions: The core microbiome and shared ASV analyses revealed that several genes are shared between oral and intestinal environments in patients with colorectal polyps, indicating the oral–gut translocation of periodontitis–related bacteria. Further large–scale studies are needed to elucidate their involvement in CRC.

    DOI: 10.1101/2024.04.29.591540

    researchmap

  • Polyacrylic acid-polyvinylpyrrolidone complex for achieving hemostasis after hemodialysis: study protocol for an open-label crossover randomized controlled trial (PAA-PVP study)

    Ryohei Terashima, Mototsugu Tanaka, Atsushi Hashimoto, Daiki Omori, Takahiro Tanaka, Haruna Miyazawa, Masahiro Ishizawa, Yoshihiko Tomita, Tomoko Ito, Yoshiyuki Koyama, Kokichi Saito, Suguru Yamamoto, Shin Goto, Ichiei Narita

    2024.4

  • Postmarket safety communications on drugs approved in Japan: A 25-year analysis. Reviewed International journal

    Yusuke Tanaka, Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Makoto Miyazawa, Mutsuhiro Ikuma, Yoshihiko Tomita

    Clinical and translational science   17 ( 4 )   e13803   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Drug safety communications (DSCs) are essential tools for communicating important postmarket serious drug safety information to healthcare professionals and patients. Previous studies characterized DSCs issued by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA); however, knowledge about the activities of the Pharmaceuticals and Medical Devices Agency (PMDA)/the Ministry of Health, Labor and Welfare (MHLW) is limited. This study characterized DSCs by the PMDA/MHLW in comparison with previously reported DSCs by the FDA and the EMA. We retrospectively analyzed 37 DSCs of 41 adverse drug reactions (ADRs) for 33 drugs in Japan from 1997 to 2022. Most DSCs were related to non-oncology drugs (30/37, 81.1%), and the median (interquartile range) time from approval to DSC issuance was 19 (10-51) months. Notably, the regulatory review reports and the latest labels before DSC issuance did not describe 16/28 (57.1%) and 12/37 (32.4%) of the ADRs related to DSCs, respectively. Most DSCs resulted in label revisions (36/37, 97.3%) and seven drugs were eventually withdrawn. Some DSC characteristics are similar among the PMDA/MHLW, the FDA, and the EMA; however, the number, contents, and range of new safety issues addressed by DSCs differ among the three jurisdictions. Our study emphasized the importance of continuous efforts to gather postmarket drug safety information because substantial ADRs that led to DSCs were recognized after approval and were associated with critical label revisions and withdrawals. Future studies are required to address global challenges for regulatory harmonization of safety-related regulatory actions.

    DOI: 10.1111/cts.13803

    PubMed

    researchmap

  • Removal of α1-Microglobulin Using Post-Dilution Online Hemodiafiltration with Polymethylmethacrylate Membrane: An Open-Label, Single-Arm Study. Reviewed International journal

    Shiori Yoshida, Suguru Yamamoto, Daisuke Miyauchi, Ryohei Terashima, Atsushi Hashimoto, Haruna Miyazawa, Takahiro Tanaka, Masahiro Ishizawa, Mototsugu Tanaka, Yoshihiko Tomita, Ikuo Aoike, Shin Goto, Ichiei Narita

    Blood purification   1 - 7   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: The removal of low- and medium-molecular-weight proteins has been improved with online hemodiafiltration (OL-HDF) and hemodialysis using high-flux membranes; however, the outcomes of patients with end-stage kidney disease (ESKD) undergoing dialysis treatment are still worse than in the general population. α1-Microglobulin (α1-m), with a molecular weight of 33,000 Da, may contribute to dialysis-related disorders and mortality. However, the removal is insufficient even with current OL-HDF using the polysulfone (PS) membrane, which is common in Japan. Polymethylmethacrylate (PMMA) membranes can remove medium- to high-molecular-weight proteins by adsorption. This study aimed to assess the efficacy of removing medium- to high-molecular-weight proteins, such as α1-m and β2-microglobulin (β2-m), through post-dilution OL-HDF with PMMA (Post-PMMA). The assessment was conducted in comparison to pre-dilution OL-HDF with PS (Pre-PS), using an open-label, single-arm study. METHODS: Seven patients with ESKD on Pre-PS underwent Post-PMMA with replacement volume of 30 mL/min (low flow) and 50 mL/min (high flow). Clearance and removal rates of α1-m, β2-m, small molecules, inflammatory cytokines, and albumin were measured at 60 and 240 min of treatment. RESULTS: Clearance rates of α1-m at 60 min were -2.8 ± 5.2 mL/min with Pre-PS, -0.4 ± 2.6 mL/min with Post-PMMA (low), and 0.6 ± 3.4 mL/min with Post-PMMA (high). The removal rate of α1-m was higher in Post-PMMA than that in Pre-HDF-PS (Post-PMMA [high] 17.7 ± 5.9%, Post-PMMA [low] 15.0 ± 5.6%, and Pre-PS 4.1 ± 5.5%). Adsorption clearance of β2-m was increased with Post-PMMA. Albumin leakage in Post-PMMA was not higher than that in Pre-PS. CONCLUSION: The removal rate of α1-m with Post-PMMA was higher than that with Pre-PS. The PMMA membrane adsorbed β2-m, suggesting the removal effect of medium- to high-molecular-weight proteins by the adsorption method. Since Post-PMMA effectively removes α1-m without excessive albumin leakage, it will be useful for patients with ESKD, especially those with a poor nutritional status.

    DOI: 10.1159/000534459

    PubMed

    researchmap

  • Conditional early approval for new drug applications in Japan: Current and emerging issues. Reviewed International journal

    Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Mutsuhiro Ikuma

    Clinical and translational science   16 ( 8 )   1289 - 1293   2023.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/cts.13536

    PubMed

    researchmap

  • Effect of Locally Delivered Minocycline on the Profile of Subgingival Bacterial Genera in Patients with Periodontitis: A Prospective Pilot Study. Reviewed International journal

    Toshiya Morozumi, Yohei Nakayama, Satoshi Shirakawa, Kentaro Imamura, Kaname Nohno, Takatoshi Nagano, Haruna Miyazawa, Takahiro Hokari, Ryo Takuma, Shuntaro Sugihara, Kazuhiro Gomi, Atsushi Saito, Yorimasa Ogata, Motohiro Komaki

    Biomolecules   12 ( 5 )   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This prospective pilot study aimed to evaluate the effect of minocycline-HCl ointment (MO), locally delivered as an adjunct to scaling and root planing (SRP), on subgingival microflora. A total of 59 periodontitis patients received SRP as an initial periodontal therapy. In the selected periodontal pockets with probing depths (PD) of 6-9 mm, the sites that exhibited a positive reaction following a bacterial test using an immunochromatographic device were subsequently treated with MO (SRP + MO group, n = 25). No additional treatment was performed at sites showing a negative reaction (SRP group, n = 34). In addition to subgingival plaque sampling, measurement of clinical parameters including PD, clinical attachment level (CAL), bleeding on probing (BOP), plaque index and gingival index (GI) were performed at baseline and 4 weeks after the initial periodontal therapy. The subgingival microflora were assessed by terminal restriction fragment-length polymorphism analysis. Relative to baseline values, the mean scores for PD-, CAL-, BOP-, and GI-sampled sites were significantly decreased post treatment in both groups (p < 0.01). The intra-comparisons showed a significant decrease in the counts of the genera Eubacterium, Parvimonas, Filifactor, Veillonella, Fusobacterium, Porphyromonas, Prevotella, and unknown species in the SRP + MO group (p < 0.05). Inter-comparisons indicated a significant decrease in the genera Veillonella in the SRP + MO group (p = 0.01). Combination therapy of SRP and local MO induced a change in the subgingival microbial community: particularly, the number of Veillonella spp. was markedly reduced.

    DOI: 10.3390/biom12050719

    PubMed

    researchmap

  • The relationship between dental metal allergy, periodontitis, and palmoplantar pustulosis: An observational study. Reviewed

    Yurina Takaoka, Yosuke Akiba, Masako Nagasawa, Akiko Ito, Yukiko Masui, Nami Akiba, Kaori Eguchi, Haruna Miyazawa, Koichi Tabeta, Katsumi Uoshima

    Journal of prosthodontic research   66 ( 3 )   438 - 444   2021.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: This study aimed to investigate the relationship between dental metal allergy, periodontitis, and palmoplantar pustulosis among patients from a dental metal allergy clinic over a period of 8 years. METHODS: This study included 436 patients who visited our dental metal allergy clinic between April 1, 2009 and March 31, 2016. Diagnoses of skin diseases, periodontal records, dental metal series patch test results, and electron probe microanalysis (EPMA) data were obtained from medical records. Relative risk (RR) values were estimated from these data. RESULTS: Of the 359 patients who underwent the patch test, 241 showed a positive reaction. Of the 187 patients who underwent EPMA, 113 had allergenic metals in their dental prostheses. These patients were suspected to have a dental metal allergy. Furthermore, 150 of the 436 patients were diagnosed with palmoplantar pustulosis (PPP). The RR of metal allergy between patients with PPP and healthy subjects was 3.88. The RR of periodontal disease between patients with PPP and PPP-negative patients in the national average was 2.54. CONCLUSIONS: In this study, both dental metal allergy and periodontitis showed a high RR for PPP.

    DOI: 10.2186/jpr.JPR_D_20_00307

    PubMed

    researchmap

  • Impact of Local Drug Delivery of Minocycline on the Subgingival Microbiota during Supportive Periodontal Therapy: A Randomized Controlled Pilot Study. Reviewed International journal

    Haruna Miyazawa, Takako Nakajima, Makoto Horimizu, Kazuhiro Okuda, Noriko Sugita, Kyoko Yamazaki, Lu Li, Yoshiko Hayashi-Okada, Takuya Arita, Misa Nishimoto, Mieko Nishida, Robert J Genco, Kazuhisa Yamazaki

    Dentistry journal   8 ( 4 )   2020.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The aim of this study was to examine the effect of adjunct local minocycline administration on the microbiological parameters of subgingival plaque samples in the residual periodontal pockets. Ten chronic periodontitis patients under a supportive periodontal therapy regimen were recruited. After subgingival debridement, either 2% minocycline gel, Periocline™, (Test Group) or a placebo (Control Group) was administered to the selected sites once a week for three weeks. Subgingival plaque was collected at baseline, and at four weeks and eight weeks. The microbiological composition was analyzed by 16S ribosomal RNA sequencing. In the Test Group, α-diversity (evenness) decreased compared to the baseline (p = 0.005) and was lower compared to the control group at four weeks (p = 0.003). The microbial community composition between the two groups was significantly different at four weeks (p = 0.029). These changes were attributable to a decrease in the bacteria associated with periodontitis and an increase in the bacteria associated with periodontal health. Additionally, the improvement in bleeding on probing continued at eight weeks; however, there were little microbial effects of 2% minocycline gel observed at eight weeks. The control group demonstrated no change throughout the eight-week experimental period. Thus, local minocycline administration can change the subgingival microbial community of residual periodontal pockets.

    DOI: 10.3390/dj8040123

    PubMed

    researchmap

  • Corrigendum to "Indirect regulation of PCSK9 gene in inflammatory response by <i>Porphyromonas gingivalis</i> infection" [Heliyon 5 (1) (January 2019) e01111]. Reviewed

    Yokoji-Takeuchi M, Tabeta K, Takahashi N, Arimatsu K, Miyazawa H, Matsuda-Matsukawa Y, Sato K, Yamada M, Yamazaki K

    Heliyon   5 ( 2 )   e01210   2019.2

     More details

    Language:English   Publisher:ELSEVIER SCI LTD  

    DOI: 10.1016/j.heliyon.2019.e01210

    Web of Science

    PubMed

    researchmap

  • Indirect regulation of PCSK9 gene in inflammatory response by Porphyromonas gingivalis infection. Reviewed International journal

    Mai Yokoji-Takeuchi, Koichi Tabeta, Naoki Takahashi, Kei Arimatsu, Haruna Miyazawa, Yumi Matsuda-Matsukawa, Keisuke Sato, Miki Yamada, Kazuhisa Yamazaki

    Heliyon   5 ( 1 )   e01111   2019.1

     More details

    Language:English  

    Pro-protein convertase subtilisin/kexin type 9 (PCSK9), a secreted serine protease, regulates serum low-density lipoprotein (LDL) cholesterol levels by targeting the degradation of LDL receptor (LDLR) in the liver. Although previous reports describe elevated levels of PCSK9 in patients with periodontitis, the mechanisms that trigger this increase in serum PCSK9 levels and induce the related inflammatory response remain unclear. In an unc93b1-deficient mouse of Porphyromonas gingivalis infection, nucleic acid antigen recognition via Toll-like receptors was found to promote PCSK9 production, suggesting an indirect role for tumor necrosis factor-α as an inducer of PCSK9 in contrast to that reported in previous studies. Furthermore, PCSK9 production was independent of the TIR domain-containing adapter-inducing interferon-β-dependent signaling pathway. These results indicate that changes in LDLR expression precede an increase in the serum PCSK9 level in the context of an infectious disease such as periodontitis.

    DOI: 10.1016/j.heliyon.2018.e01111

    PubMed

    researchmap

  • β2-Microglobulin and Neutrophil Gelatinase-Associated Lipocalin, Potential Novel Urine Biomarkers in Periodontitis: A Cross-Sectional Study in Japanese. Reviewed International journal

    Mayuka Nakajima, Michihiro Hosojima, Koichi Tabeta, Sayuri Miyauchi, Miki Yamada-Hara, Naoki Takahashi, Haruna Miyazawa, Yumi Matsuda-Matsukawa, Keisuke Sato, Noriko Sugita, Yasutaka Komatsu, Tomomi Ishikawa, Kazuhiro Akiishi, Kazuhisa Yamazaki, Kiminori Kato, Akihiko Saito, Hiromasa Yoshie

    International journal of dentistry   2019   1394678 - 1394678   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Objectives: Several serum biomarkers have been reported to increase in periodontitis patients as possible mediators linking periodontal inflammation to systemic diseases. However, the relationship between periodontitis and urine biomarkers is still unclear. The aim of this cross-sectional study was to investigate potential urine biomarkers of periodontitis in a Japanese population. Materials and Methods: This study included 108 male subjects, and microbiological and clinical parameters were evaluated as a periodontitis marker. The correlation between nine urine biomarkers (typically used to diagnose kidney disease) and periodontal parameters was analyzed. Based on the findings, β2-microglobulin (β2-MG) and neutrophil gelatinase-associated lipocalin (NGAL) were selected for comparison and multivariate regression analysis, and the Kruskal-Wallis test followed by Bonferroni correction was used to identify differences in their concentrations between the three periodontitis groups (severe, moderate, and no/mild periodontitis). Results: β2-MG and NGAL exhibited a significant correlation with clinical parameters of periodontitis. The prevalence of clinical parameters such as bleeding on probing and number of sites with probing depth (PD) ≥ 6 mm were greater in the β2-MG high group (≥300 μg/g creatinine) than in the normal group (P=0.017 and 0.019, respectively). Multivariate regression analysis indicated that the number of sites with PD ≥ 6 mm was independently associated with urine β2-MG. Moreover, the number of sites with the clinical attachment level (CAL) ≥ 6 mm was greater in the NGAL high group (highest quartile) (P=0.041). Multivariate regression analysis showed that the number of sites with CAL ≥ 6 mm was associated independently with urine NGAL. Finally, β2-MG was significantly higher in the severe periodontitis subjects compared to the no/mild periodontitis subjects. Conclusion: The significant association between urine β2-MG or NGAL and periodontitis was revealed. These biomarkers can potentially be used to screen for or diagnose periodontitis. This trial is registered with the UMIN Clinical Trials Registry UMIN000013485.

    DOI: 10.1155/2019/1394678

    PubMed

    researchmap

  • Increased serum PCSK9, a potential biomarker to screen for periodontitis, and decreased total bilirubin associated with probing depth in a Japanese community survey Reviewed

    K. Tabeta, M. Hosojima, M. Nakajima, S. Miyauchi, H. Miyazawa, N. Takahashi, Y. Matsuda, N. Sugita, Y. Komatsu, K. Sato, T. Ishikawa, K. Akiishi, K. Yamazaki, K. Kato, A. Saito, H. Yoshie

    Journal of Periodontal Research   53 ( 3 )   446 - 456   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Blackwell Munksgaard  

    Background and Objectives: Previous reports suggest that several serum biomarkers play roles in the pathogenesis, inflammatory response, and oxidative stress in periodontitis caused by bacterial infections, linking chronic periodontitis to atherosclerotic vascular disease (ASVD). The aim of this preliminary study was to investigate, in a Japanese cross-sectional community survey, potential serum biomarkers of periodontitis that are associated with ASVD and chronic periodontitis. Material and Methods: The study cohort included a total of 108 male subjects who underwent annual health examinations. Serum biomarkers (high-sensitivity C-reactive protein [hs-CRP], proprotein convertase subtilisin/kexin type 9 [PCSK9], interleukin-6, tumor necrosis factor-α, soluble CD14, myeloperoxidase, matrix metalloproteinase-3, adiponectin, total bilirubin [TBIL], and serum lipids) were analyzed to determine their association (if any) with periodontal parameters. Aortic stiffness was evaluated using the brachial-ankle aortic pulse wave velocity (PWV) index and the cardio-ankle vascular index (CAVI). Results: The concentrations of PCSK9 and hs-CRP were increased (P =.001 and.042, respectively), and the concentration of TBIL was decreased (P =.046), in subjects with periodontal disease (determined as a probing depth of ≥4 mm in at least one site) compared with periodontally healthy subjects. The ratio of low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol and the concentrations of triglycerides, remnant-like particles-cholesterol, and oxidized LDL were elevated in subjects with periodontal disease compared with periodontally healthy subjects (P =.038,.007,.002, and.049, respectively). Multivariate regression analyses indicated that the number of sites with a pocket depth of ≥4 mm was associated with the concentration of PCSK9 and inversely associated with the concentration of TBIL independently (standardized β =.243, P =.040
    standardized β = −.443, P =.0002
    respectively). Analysis of receiver operating characteristic curves of PCSK9 indicated moderate accuracy for predicting the presence of disease sites (probing depth ≥ 4 mm) (area under the curve = 0.740). No significance in the values of PWV and CAVI was observed between subjects with periodontal disease and periodontally healthy subjects. Conclusion: In Japanese male subjects, the concentrations of serum PCSK9 and TBIL were correlated with periodontal parameters. Moreover, PCSK9 could be a candidate biomarker for diagnosing chronic periodontitis, and may also have potential to evaluate the risk for periodontitis to cause ASVD. Longitudinal studies of larger populations are necessary to confirm the exact association of periodontitis with increased serum PCSK9 and decreased TBIL.

    DOI: 10.1111/jre.12533

    Scopus

    PubMed

    researchmap

  • Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota Reviewed

    Kei Arimatsu, Hitomi Yamada, Haruna Miyazawa, Takayoshi Minagawa, Mayuka Nakajima, Mark I. Ryder, Kazuyoshi Gotoh, Daisuke Motooka, Shota Nakamura, Tetsuya Iida, Kazuhisa Yamazaki

    SCIENTIFIC REPORTS   4   4828   2014.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Periodontitis has been implicated as a risk factor for metabolic disorders such as type 2 diabetes, atherosclerotic vascular diseases, and non-alcoholic fatty liver disease. Although bacteremias from dental plaque and/or elevated circulating inflammatory cytokines emanating from the inflamed gingiva are suspected mechanisms linking periodontitis and these diseases, direct evidence is lacking. We hypothesize that disturbances of the gut microbiota by swallowed bacteria induce a metabolic endotoxemia leading metabolic disorders. To investigate this hypothesis, changes in the gut microbiota, insulin and glucose intolerance, and levels of tissue inflammation were analysed in mice after oral administration of Porphyromonas gingivalis, a representative periodontopathogens. Pyrosequencing revealed that the population belonging to Bacteroidales was significantly elevated in P. gingivalis-administered mice which coincided with increases in insulin resistance and systemic inflammation. In P. gingivalis-administered mice blood endotoxin levels tended to be higher, whereas gene expression of tight junction proteins in the ileum was significantly decreased. These results provide a new paradigm for the interrelationship between periodontitis and systemic diseases.

    DOI: 10.1038/srep04828

    Web of Science

    PubMed

    researchmap

  • Natural killer T cells mediate alveolar bone resorption and a systemic inflammatory response in response to oral infection of mice with Porphyromonas gingivalis Reviewed

    Y. Aoki-Nonaka, T. Nakajima, S. Miyauchi, H. Miyazawa, H. Yamada, H. Domon, K. Tabeta, K. Yamazaki

    JOURNAL OF PERIODONTAL RESEARCH   49 ( 1 )   69 - 76   2014.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Background and Objective: T and B cells are known to be involved in the disease process of periodontitis. However, the role of natural killer T cells in the pathogenesis of periodontitis has not been clarified.
    Materials and Methods: To examine the role of these cells, C57BL/6J (wild-type), CD1d(-/-) and alpha-galactosylceramide (alpha GC)-stimulated wild-type mice were orally infected with Porphyromonas gingivalis strain W83.
    Results: Apart from CD1d(-/-) mice, the level of alveolar bone resorption was elevated by the infection and was further accelerated in alpha GC-stimulated mice. The infection induced elevated levels of serum amyloid A and P. gingivalis-specific IgG in the sera, although the degree of elevation was much smaller in the CD1d(-/-) mice. Infection-induced RANKL elevation was only observed in aGC-stimulated mice. Although the cytokines produced by splenocytes were mainly T-helper 1 type in wild-type mice, those in alpha GC-stimulated mice were predominantly T-helper 2 type. In the liver, the infection demonstrated no effect on the gene expression for interferon-gamma, interleukin-4 and RANKL except alpha GC-stimulated mice in which the infection upregulated the gene expressions.
    Conclusion: This study is the first to show that natural killer T cells upregulated systemic and local inflammatory responses induced by oral infection with P. gingivalis, thereby contributing to the progression of alveolar bone resorption.

    DOI: 10.1111/jre.12080

    Web of Science

    PubMed

    researchmap

  • Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice Reviewed

    Haruna Miyazawa, Koichi Tabeta, Sayuri Miyauchi, Yukari Aoki-Nonaka, Hisanori Domon, Tomoyuki Honda, Takako Nakajima, Kazuhisa Yamazaki

    LIPIDS IN HEALTH AND DISEASE   11   121   2012.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Periodontal disease is suggested to increase the risk of atherothrombotic disease by inducing dyslipidemia. Recently, we demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9), which is known to play a critical role in the regulation of circulating low-density lipoprotein (LDL) cholesterol levels, is elevated in periodontitis patients. However, the underlying mechanisms of elevation of PCSK9 in periodontitis patients are largely unknown. Here, we explored whether Porphyromonas gingivalis, a representative periodontopathic bacterium, -induced inflammatory response regulates serum PCSK9 and cholesterol levels using animal models.
    Methods: We infected C57BL/6 mice intraperitoneally with Porphyromonas gingivalis, a representative strain of periodontopathic bacteria, and evaluated serum PCSK9 levels and the serum lipid profile. PCSK9 and LDL receptor (LDLR) gene and protein expression, as well as liver X receptors (Lxrs), inducible degrader of the LDLR (Idol), and sterol regulatory element binding transcription factor (Srebf)2 gene expression, were examined in the liver.
    Results: P. gingivalis infection induced a significant elevation of serum PCSK9 levels and a concomitant elevation of total and LDL cholesterol compared with sham-infected mice. The LDL cholesterol levels were significantly correlated with PCSK9 levels. Expression of the Pcsk9, Ldlr, and Srebf2 genes was upregulated in the livers of the P. gingivalis-infected mice compared with the sham-infected mice. Although Pcsk9 gene expression is known to be positively regulated by sterol regulatory element binding protein (SREBP)2 (human homologue of Srebf2), whereas Srebf2 is negatively regulated by cholesterol, the elevated expression of Srebf2 found in the infected mice is thought to be mediated by P. gingivalis infection.
    Conclusions: P. gingivalis infection upregulates PCSK9 production via upregulation of Srebf2, independent of cholesterol levels. Further studies are required to elucidate how infection regulates Srebf2 expression and subsequently influences lipid metabolism.

    DOI: 10.1186/1476-511X-11-121

    Web of Science

    PubMed

    researchmap

  • Oral infection with Porphyromonas gingivalis and systemic cytokine profile in C57BL/6.KOR-ApoEshl mice Reviewed

    S. Miyauchi, T. Maekawa, Y. Aoki, H. Miyazawa, K. Tabeta, T. Nakajima, K. Yamazaki

    JOURNAL OF PERIODONTAL RESEARCH   47 ( 3 )   402 - 408   2012.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Background and Objective: Periodontal infection affects atherosclerotic diseases, such as coronary heart diseases. Mouse models have revealed that oral infection with Porphyromonas gingivalis induces changes in inflammatory-and lipid metabolism-related gene expression, regardless of the development of atherosclerotic lesions. However, the serum protein expression profile in the oral infection model has not been investigated. The present study aimed to analyse the effect of oral infection with P. gingivalis on the expression levels of multiple cytokines in the serum in apolipoprotein E-deficient mice by using a cytokine antibody array. Material and Methods: C57BL/ 6. KOR-Apoe shl mice were orally infected with P. gingivalis five times at 3 day intervals and were then killed. Splenocytes were isolated and analysed for proliferative activity and immunoglobulin G (IgG) production in response to in vitro restimulation with P. gingivalis. The expression levels of various cytokines in the sera were analysed using a mouse antibody array glass chip. Results: Splenocytes from P. gingivalis-infected mice demonstrated significantly greater proliferation and IgG production in response to P. gingivalis compared with those from sham-infected mice. Antibody array analysis revealed the selective upregulation of matrix metalloproteinase 3, intercellular adhesion molecule 1, insulin-like growth factor binding protein 2 and chemokine (C-X-C motif) ligand 7 and the downregulation of interleukin-17, tumor necrosis factor-a and L-selectin. Conclusion: These data demonstrate that oral infection with P. gingivalis induces alterations in systemic cytokine production. These cytokines could play roles in the development not only of periodontitis but also of atherosclerosis.

    DOI: 10.1111/j.1600-0765.2011.01441.x

    Web of Science

    PubMed

    researchmap

  • Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration Reviewed

    Haruna Miyazawa, Tomoyuki Honda, Sayuri Miyauchi, Hisanori Domon, Takafumi Okui, Takako Nakajima, Koichi Tabeta, Kazuhisa Yamazaki

    CLINICA CHIMICA ACTA   413 ( 1-2 )   154 - 159   2012.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Background: Periodontal disease increases the risk of atherothrombotic disease, and high concentrations of low density lipoprotein (LDL) cholesterol are considered to be involved: however, the underlying mechanisms are largely unknown. Recent studies demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a critical role in circulating LDL cholesterol concentrations. The aim of the present study is to analyze serum PCSK9 concentrations and their relation to lipoprotein concentrations in periodontitis patients.
    Methods: Sera were obtained from 40 periodontitis patients and 30 control subjects. PCSK9 concentrations, high-sensitivity C-reactive protein (hs-CRP), IL-6, TNF-alpha and Porphyromonas gingivalis antibodies were measured by ELISA, and lipid profiles were determined by a commercial laboratory.
    Results: Periodontitis patients demonstrated significantly higher serum antibody titer to P. gingivalis and hs-CRP concentrations than control subjects, suggesting infection with P. gingivalis and a systemic inflammatory response. PCSK9 concentrations in periodontitis patients were significantly higher than those in control subjects. However, the concentrations of total and LDL cholesterols were not significantly different between periodontitis patients and control subjects. Moreover, no correlations were observed between PCSK9 concentrations and lipid profiles.
    Conclusion: Periodontal infection upregulates PCSK9 production. However, further studies are required to elucidate how periodontal infection affects PCSK9 concentrations and subsequent lipid metabolism. (C) 2011 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.cca.2011.09.023

    Web of Science

    PubMed

    researchmap

  • Chronic Oral Infection with Porphyromonas gingivalis Accelerates Atheroma Formation by Shifting the Lipid Profile Reviewed

    Tomoki Maekawa, Naoki Takahashi, Koichi Tabeta, Yukari Aoki, Hirotaka Miyashita, Sayuri Miyauchi, Haruna Miyazawa, Takako Nakajima, Kazuhisa Yamazaki

    PLOS ONE   6 ( 5 )   e20240   2011.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PUBLIC LIBRARY SCIENCE  

    Background: Recent studies have suggested that periodontal disease increases the risk of atherothrombotic disease. Atherosclerosis has been characterized as a chronic inflammatory response to cholesterol deposition in the arteries. Although several studies have suggested that certain periodontopathic bacteria accelerate atherogenesis in apolipoprotein E-deficient mice, the mechanistic link between cholesterol accumulation and periodontal infection-induced inflammation is largely unknown.
    Methodology/Principal Findings: We orally infected C57BL/6 and C57BL/6. KOR-Apoe(shl) (B6.Apoeshl) mice with Porphyromonas gingivalis, which is a representative periodontopathic bacterium, and evaluated atherogenesis, gene expression in the aorta and liver and systemic inflammatory and lipid profiles in the blood. Furthermore, the effect of lipopolysaccharide (LPS) from P. gingivalis on cholesterol transport and the related gene expression was examined in peritoneal macrophages. Alveolar bone resorption and elevation of systemic inflammatory responses were induced in both strains. Despite early changes in the expression of key genes involved in cholesterol turnover, such as liver X receptor and ATP-binding cassette A1, serum lipid profiles did not change with short-term infection. Long-term infection was associated with a reduction in serum high-density lipoprotein (HDL) cholesterol but not with the development of atherosclerotic lesions in wild-type mice. In B6.Apoeshl mice, long-term infection resulted in the elevation of very low-density lipoprotein (VLDL), LDL and total cholesterols in addition to the reduction of HDL cholesterol. This shift in the lipid profile was concomitant with a significant increase in atherosclerotic lesions. Stimulation with P. gingivalis LPS induced the change of cholesterol transport via targeting the expression of LDL receptor-related genes and resulted in the disturbance of regulatory mechanisms of the cholesterol level in macrophages.
    Conclusions/Significance: Periodontal infection itself does not cause atherosclerosis, but it accelerates it by inducing systemic inflammation and deteriorating lipid metabolism, particularly when underlying hyperlidemia or susceptibility to hyperlipidemia exists, and it may contribute to the development of coronary heart disease.

    DOI: 10.1371/journal.pone.0020240

    Web of Science

    PubMed

    researchmap

▶ display all

MISC

  • イエローレター及びブルーレターからみた製造販売承認後の安全性情報の重要性

    田中 雄介, 田中 基嗣, 宮沢 春菜, 寺島 瞭平, 宮澤 誠, 田中 崇裕, 伊熊 睦博

    日本臨床薬理学会学術総会抄録集   44   2-C-P-H3   2023

     More details

    Language:Japanese   Publisher:一般社団法人 日本臨床薬理学会  

    【目的】医薬品は、製造販売承認後に様々な背景を有する多くの患者で使用されることで、新たなリスクが明らかになることは少なくない。このため、製造販売業者は、承認後も安全性情報を収集し、必要に応じて規制当局への報告と添付文書の改訂を行っている。通常の添付文書改訂よりも強い注意喚起が必要な場合には、厚生労働省の指示に基づいて、製造販売業者は、緊急安全性情報(イエローレター)及び安全性速報(ブルーレター)を発行する。本研究では、イエローレター及びブルーレターのレビューに基づいて、製造販売承認後の安全性情報の重要性を検討した。

    【方法】医薬品等安全性情報報告制度の運用が開始された1997年7月から2022年12月までに医薬品に対して配布されたイエローレター及びブルーレターを対象とした。データソースとして、該当する医薬品添付文書及び審査報告書を使用した。複数の薬物有害反応が報告されているレターについては、まとめて1件として扱い、そのすべてが添付文書または審査報告書に記載されている場合を記載ありと定めた。

    【結果】研究対象期間内に、医薬品32品目に対してイエローレター16件及びブルーレター20件(計36件)が配布された。7件が抗悪性腫瘍剤(19.4%)、29件が非抗悪性腫瘍剤に対するレターであった(80.6%)。承認日からレター発行までの期間の中央値(四分位範囲)は、20(10-55)ヵ月であった。レターに関連した薬物有害反応のうち、承認時の審査報告書及びレター発行前の医薬品添付文書に未記載であったものは、それぞれ13/27(48.1%)及び11/36(30.6%)であった。これらの薬物有害反応について、承認前の臨床試験で有害事象が確認されていた10/14品目(71.4%)では、製造販売後調査の必要性が審査報告書に記載されていた。35/36(97.1%)で添付文書が改訂され、特に27/36(75.0%)で「警告」又は「禁忌」の項が修正された。レター発行後に7品目が販売中止となった。

    【結論】イエローレター及びブルーレターが発行された薬物有害反応の約半数は、承認時点で明らかでなかった。製造販売承認後の継続的な安全性情報収集の重要性が確認された。

    DOI: 10.50993/jsptsuppl.44.0_2-c-p-h3

    researchmap

  • 本邦の医薬品承認審査における継続審議品目に関する検討

    宮澤誠, 田中基嗣, 田中雄介, 宮沢春菜, 寺島瞭平, 田中崇裕, 伊熊睦博

    レギュラトリーサイエンス学会誌   13 ( Supplement )   2023

  • わが国の医薬品の条件付き早期承認制度における課題

    田中基嗣, 宮沢春菜, 寺島瞭平, 宮澤誠, 田中雄介, 田中崇裕, 伊熊睦博

    レギュラトリーサイエンス学会誌   13 ( Supplement )   2023

  • Field Test of Health Information for Self-Management of Exercise, Oral Health, Nutrition, and Rest

    渡邊佳代, 大井悠成, 山崎幸, 武政睦子, 宮沢春菜, 岡田美保子

    医療情報学連合大会論文集(CD-ROM)   43rd   2023

  • Leveraging use of self-management data in oral health-Challenges and Potential

    42   352 - 354   2022.11

     More details

    Authorship:Lead author, Corresponding author  

    researchmap

  • 運動・口腔保健・栄養・休養の自己管理のための保健医療情報 健康増進に寄与する口腔保健データ管理と活用の可能性

    宮沢 春菜

    医療情報学連合大会論文集   41回   456 - 456   2021.11

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese   Publisher:(一社)日本医療情報学会  

    researchmap

  • 広汎型重度慢性歯周炎患者に歯周矯正を応用した一症例

    多部田康一, 宮澤春菜, 竹内麻衣, 松岸葵, 都野隆博

    日本歯周病学会会誌(Web)   62   2020

  • 歯周炎患者唾液細菌叢が腸内細菌叢に与える影響の解析

    山崎 恭子, 中島 貴子, 宮澤 春菜, 佐藤 圭祐, 高橋 直紀, 原 実生, 竹内 麻衣, 山崎 和久

    日本歯周病学会会誌   61 ( 秋季特別 )   141 - 141   2019.10

     More details

    Language:Japanese   Publisher:(NPO)日本歯周病学会  

    researchmap

  • 歯周炎患者における腸内細菌叢の解析

    山崎 恭子, 中島 貴子, 宮沢 春菜, 伊藤 晴江, 佐藤 圭祐, 原 実生, 竹内 麻衣, 高橋 直紀, 森田 英利, 須田 亙, 服部 正平, 山崎 和久

    腸内細菌学雑誌   33 ( 2 )   116 - 116   2019.4

     More details

    Language:Japanese   Publisher:(公財)腸内細菌学会  

    researchmap

  • 歯周炎患者における腸内細菌叢の解析

    山崎恭子, 山崎恭子, 中島貴子, 宮沢春菜, 宮沢春菜, 伊藤晴江, 佐藤圭祐, 佐藤圭祐, 原実生, 原実生, 竹内麻衣, 竹内麻衣, 高橋直紀, 森田英利, 須田亙, 服部正平, 山崎和久

    腸内細菌学雑誌   33 ( 2 )   116 - 116   2019.4

     More details

    Language:Japanese   Publisher:(公財)日本ビフィズス菌センター  

    J-GLOBAL

    researchmap

  • 歯周炎患者唾液細菌叢が腸内細菌叢に与える影響の解析

    山崎恭子, 山崎恭子, 中島貴子, 宮澤春菜, 佐藤圭祐, 高橋直紀, 原実生, 原実生, 竹内麻衣, 山崎和久

    日本歯周病学会会誌(Web)   61   2019

  • P.gingivalis感染におけるPCSK9産生の誘導機構

    横地麻衣, 横地麻衣, 多部田康一, 高橋直紀, 高橋直紀, 宮澤春菜, 松田由実, 佐藤圭祐, 山田実生, 山田実生, SULIJAYA Benso, SULIJAYA Benso, 山崎和久

    新潟歯学会雑誌   48 ( 2 )   110 - 110   2018.12

     More details

    Language:Japanese   Publisher:新潟歯学会  

    J-GLOBAL

    researchmap

  • 歯周病患者における機能指標としての咀嚼機能検査の有用性について

    宮沢 春菜, 中島 貴子, 松川 由実, 清水 伸太郎, 古市 保志, 根本 英二, 高井 英樹, 中山 洋平, 小方 頼昌, 岩崎 拓也, 石原 裕一, 大井 麻子, 齋藤 淳, 藤原 千春, 村上 伸也, 畑中 加珠, 高柴 正悟, 武田 克浩, 藤田 剛, 栗原 英見, 山崎 和久

    日本歯周病学会会誌   60 ( 秋季特別 )   136 - 136   2018.10

     More details

    Language:Japanese   Publisher:(NPO)日本歯周病学会  

    researchmap

  • 塩酸ミノサイクリン局所投与がサポーティブペリオドンタルセラピー(SPT)期歯周炎患者の歯肉縁下細菌叢に及ぼす影響(第II報)

    宮沢 春菜, 中島 貴子, 堀水 慎, 杉田 典子, 奥田 一博, 山崎 和久, Li Lu, Genco Robert

    日本歯周病学会会誌   59 ( 秋季特別 )   190 - 190   2017.11

     More details

    Language:Japanese   Publisher:(NPO)日本歯周病学会  

    researchmap

  • 歯周炎患者腸内細菌叢における口腔内由来細菌の比率

    山崎恭子, 中島貴子, 高橋直紀, 宮澤春菜, 皆川高嘉, 佐藤圭祐, 伊藤晴江, 山崎和久

    日本歯科保存学会学術大会プログラムおよび講演抄録集(Web)   147th   88 (WEB ONLY) - 88   2017.10

     More details

    Language:Japanese   Publisher:(NPO)日本歯科保存学会  

    J-GLOBAL

    researchmap

  • 塩酸ミノサイクリン局所投与がサポーティブペリオドンタルセラピー(SPT)期歯周炎患者の歯肉縁下細菌叢に及ぼす影響(第I報)

    中島 貴子, 宮沢 春菜, 堀水 慎, 杉田 典子, 奥田 一博, 山崎 和久, Li Lu, Genco Robert

    特定非営利活動法人日本歯科保存学会学術大会プログラムおよび講演抄録集   147回   195 - 195   2017.10

     More details

    Language:Japanese   Publisher:(NPO)日本歯科保存学会  

    researchmap

  • 歯周炎患者における腸内細菌叢の解析

    中島貴子, 中島貴子, 高橋直紀, 高橋直紀, 高橋直紀, 皆川高嘉, 皆川高嘉, 宮沢春菜, 宮沢春菜, 伊藤晴江, 伊藤晴江, 佐藤圭祐, 佐藤圭祐, 山崎和久

    日本歯周病学会会誌(Web)   59 ( 春季特別 )   129 - 129   2017.4

     More details

    Language:Japanese   Publisher:(NPO)日本歯周病学会  

    J-GLOBAL

    researchmap

  • 細菌抗原によるPCSK9産生の誘導機構

    横地麻衣, 横地麻衣, 多部田康一, 宮澤春菜, 野中由香莉, 高橋直紀, 松田由実, 松田由実, 佐藤圭祐, 佐藤圭祐, 山田実生, 山田実生, 伊藤晴江, 中島貴子, 山崎和久

    日本歯科保存学会学術大会プログラムおよび講演抄録集(Web)   145th   ROMBUNNO.P94 (WEB ONLY) - 145   2016.10

     More details

    Language:Japanese   Publisher:(NPO)日本歯科保存学会  

    J-GLOBAL

    researchmap

  • 歯周炎と血液・尿中バイオロジカルマーカーとの関連解析

    中島麻由佳, 中島麻由佳, 多部田康一, 宮内小百合, 杉田典子, 小松康高, 本田朋之, 高橋直紀, 宮澤春菜, 有松圭, 皆川高嘉, 松田由実, 松田由実, 佐藤圭祐, 佐藤圭祐, 山崎和久, 吉江弘正

    日本歯科保存学会学術大会プログラムおよび講演抄録集(Web)   143rd   P126 (WEB ONLY) - 197   2015.11

     More details

    Language:Japanese   Publisher:(NPO)日本歯科保存学会  

    J-GLOBAL

    researchmap

  • 歯周炎患者におけるPISAと血中マーカーとの関連性

    本田 朋之, 宮沢 春菜, 野中 由香莉, 高橋 直紀, 多部田 康一, 中島 貴子, 山崎 和久

    日本歯周病学会会誌   57 ( 秋季特別 )   127 - 127   2015.8

     More details

    Language:Japanese   Publisher:(NPO)日本歯周病学会  

    researchmap

  • フレアアウトを伴う広汎型重度慢性歯周炎患者に歯周矯正治療を行った一症例

    多部田 康一, 宮沢 春菜, 山崎 和久, 吉江 弘正

    日本歯周病学会会誌   57 ( 秋季特別 )   149 - 149   2015.8

     More details

    Language:Japanese   Publisher:(NPO)日本歯周病学会  

    researchmap

  • 歯周炎患者におけるPISAと血中マーカーとの関連性

    本田朋之, 本田朋之, 宮沢春菜, 宮沢春菜, 野中由香莉, 野中由香莉, 高橋直紀, 高橋直紀, 多部田康一, 中島貴子, 山崎和久

    日本歯周病学会会誌(Web)   57   2015

  • Porphyromonas gingivalis経口投与によるマウス腸内細菌叢の変動と内毒素血症の関連

    有松圭, 有松圭, 山田ひとみ, 山田ひとみ, 宮内小百合, 宮澤春菜, 宮澤春菜, 中島麻由佳, 中島麻由佳, 多部田康一, 中島貴子, 山崎和久

    日本歯周病学会学術大会プログラムおよび講演抄録集   57th   2014

  • Porphyromonas gingivalis経口投与はマウス腸内細菌叢を変動させインスリン抵抗性を誘導する

    有松圭, 有松圭, 山田ひとみ, 山田ひとみ, 宮内小百合, 宮沢春菜, 中島麻由佳, 中島麻由佳, 多部田康一, 中島貴子, 山崎和久

    新潟歯学会雑誌   44 ( 2 )   2014

  • マウスPorphyromonas gingivalis口腔感染で誘導される小胞体ストレス応答と歯槽骨吸収の関連

    山田ひとみ, 山田ひとみ, 土門久哲, 宮内小百合, 宮澤春菜, 宮澤春菜, 多部田康一, 中島貴子, 山崎和久

    日本歯周病学会学術大会プログラムおよび講演抄録集   57th   2014

  • Porphyromonas gingivalis口腔感染マウスモデルにおいて小胞体ストレスは破骨細胞形成に関与し歯槽骨吸収を誘導する

    山田ひとみ, 山田ひとみ, 土門久哲, 宮内小百合, 宮内小百合, 宮沢春菜, 宮沢春菜, 中島貴子, 多部田康一, 山崎和久

    新潟歯学会雑誌   43 ( 2 )   2013

  • Porphyromonas gingivalis口腔感染マウスモデルで誘導されるインスリン抵抗性は脂肪組織及び肝臓における炎症反応と関連する

    有松圭, 土門久哲, 山田ひとみ, 宮内小百合, 宮沢春菜, 皆川高嘉, 中島麻由佳, 中島貴子, 多部田康一, 山崎和久

    日本歯周病学会学術大会プログラムおよび講演抄録集   56th   2013

▶ display all

Awards

  • JADR・GC Young Investigator Award

    2012.12   Japanese Association for Dental Research  

    Haruna Miyazawa

     More details

Research Projects

  • 本邦の医薬品開発における臨床試験デザイン選択の現状と課題 日米欧三極の比較

    Grant number:24K13311

    2024.4 - 2027.3

    System name:科学研究費助成事業

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    宮沢 春菜

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap

  • 過疎地域在住高齢者における健康行動の効果的な自己管理及び記録情報活用の検討 ~地域包括ケアシステムモデルへの貢献を目指して~

    2023.8 - 2024.3

    System name:新潟大学U-goグラント

      More details

    Authorship:Principal investigator 

    researchmap

  • PCSK9は歯周治療効果を評価する新たなバイオロジカルマーカーとなるか?

    Grant number:19K18992

    2019.4 - 2025.3

    System name:科学研究費助成事業 若手研究

    Research category:若手研究

    Awarding organization:日本学術振興会

    宮沢 春菜

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    血中コレステロールレベルを調節する分子であるProprotein convertase subtilisin/kexin type 9 (PCSK9)の血清レベルは,健常者と比較して歯周炎患者で高かった。PCSK9は歯周病検査による1歯単位の臨床指標とは別に,全身疾患に対するリスク評価も可能で,全身への影響を考慮した治療方針の選択に活用できる新たなバイオロジカルマーカーとなる可能性がある。本研究では,血清PCSK9レベルと歯周炎重症度,歯周治療前後での変動,他の臨床指標や炎症マーカーとの関連について解析し, 歯周治療効果を評価するPCSK9の有用性を明らかにする。

    researchmap

  • スケーリング後菌血症に対する高齢者生体応答の解析と光治療による予防法の確立

    Grant number:17K11984

    2017.4 - 2022.3

    System name:科学研究費助成事業 基盤研究(C)

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    両角 俊哉, 高橋 直紀, 小松 康高, 保苅 崇大, 宮沢 春菜

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    あらゆる観血処置にともない,一過性の菌血症が発生する。我々はこれまでの一連の研究で,中年期の歯周炎患者において,1) スケーリング・ルートプレーニング(SRP)後に高頻度で菌血症が発生すること,2) 抗菌薬(アジスロマイシン)併用やエルビウムヤグ(Er: YAG)レーザー治療により菌血症の発生を減少または抑制できること,3) 局所薬物配送システム(LDDS)は機械的除去療法前の使用でも歯周ポケット内環境を改善できることなどを報告してきた。一方,免疫力が低下している高齢者においては,菌血症が一過性で終わらず,全身性の高リスクとなる可能性がある。そこで,高齢者に適した安全かつ効果的な歯周治療法を確立し,超高齢社会のニーズに応えるべく、本研究では慢性歯周炎を有する高齢者のSRP時に発生する菌血症,それにともなう生体応答の解析,および光治療(Er:YAGレーザー)による菌血症予防の有効性検討を目的とする。
    具体的には、① ハンドスケーラー群:ハンドスケーラーにてSRP実施 ② エルビウムヤグ(Er: YAG)レーザー群:レーザーにて処置 の2群間で、(1) 血清中炎症性メディエイター(高感度CRP、IL-6、IFN-g、TNF-a等) (2) ストレス指標(心拍変動、血中酸素飽和度等) (3) 臨床パラメーター の経時的変化および相関関係を比較解析し、予防対策について検討する。現在、2施設において研究進行中である。

    researchmap

  • 歯周病原細菌は腸管透過性亢進に関与するか?

    2016.4 - 2019.3

    System name:科学研究費 若手研究B

    Awarding organization:日本学術振興会

    宮沢春菜

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 歯周病原細菌による腸管dysbiosisと動脈硬化との関連解明

    2014.4 - 2016.3

    System name:科学研究費 研究活動スタート支援

    Awarding organization:日本学術振興会

    宮沢春菜

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

▶ display all